Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,080
+230 (2.12%)
Aug 14, 2025, 3:30 PM KST

Chabiotech Revenue

Chabiotech had revenue of 304.14B KRW in the quarter ending March 31, 2025, with 30.87% growth. This brings the company's revenue in the last twelve months to 1.12T, up 17.57% year-over-year. In the year 2024, Chabiotech had annual revenue of 1.05T with 9.55% growth.

Revenue (ttm)
1,116.79B
Revenue Growth
+17.57%
P/S Ratio
0.76
Revenue / Employee
4.02B
Employees
278
Market Cap
846.80B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241,045.05B91.10B9.55%
Dec 31, 2023953.95B109.37B12.95%
Dec 31, 2022844.58B117.11B16.10%
Dec 31, 2021727.48B62.76B9.44%
Dec 31, 2020664.72B130.11B24.34%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,898.69B
Celltrion 3,662.23B
ALTEOGEN 151.65B
Yuhan 2,114.76B
Peptron 4.30B
SK Biopharmaceuticals 578.00B
PharmaResearch 392.31B
LigaChem Biosciences 146.42B
Revenue Rankings